Related Experiment Video
Updated: Jun 7, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Functional precision medicine: the future of cancer care
Arlet M Acanda de la Rocha1, Noah E Berlow2, Diana J Azzam1
1Department of Environmental Health Sciences, Robert Stempel College of Public Health & Social Work, Florida International University, Miami, FL, USA.
Abstract:
Functional precision medicine (FPM), combining ex vivo drug sensitivity testing with genomic profiling to identify treatment options for recurrent/refractory cancer, is feasible and poised to accelerate. This forum explores the history of FPM, recent clinical advancements, and barriers to expanding the clinical utility and accessibility for pediatric/adolescent and adult cancers.
Insights
Functional precision medicine (FPM), integrating drug sensitivity tests with genomic data, is a feasible approach to identify cancer treatments. This method shows promise for accelerating care in recurrent and refractory cancers.
Area of Science:
- Oncology
- Genomics
- Pharmacology
Background:
- Recurrent and refractory cancers present significant treatment challenges.
- Genomic profiling and ex vivo drug sensitivity testing are emerging tools in oncology.
Purpose of the Study:
- To review the history and recent advancements in Functional Precision Medicine (FPM).
- To explore barriers hindering the clinical utility and accessibility of FPM for various cancer types.
Main Methods:
- Literature review and synthesis of current research on FPM.
- Analysis of clinical data and expert opinions on FPM implementation.
Main Results:
- Functional precision medicine (FPM) is feasible and shows potential for accelerated application.
- Significant barriers exist for expanding FPM's clinical utility and accessibility.
Conclusions:
- FPM offers a viable strategy for personalized cancer treatment selection.
- Addressing identified barriers is crucial for broader FPM adoption in pediatric, adolescent, and adult oncology.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer
Cancer Survival Analysis

